Article

Bilosome Nanocarriers for Enhanced Oral Bioavailability and Cardiovascular Activity of Milrinone

Kiruthika Santhinathan1★, Susmitha Durai1★, Rijivana Sirajudeen1★, Gopinath Govindhraji1★, Saravanan Gopal1★, Gayathri Kumararaja1★★ Corresponding author

  1. 1Department of Pharmaceutics, Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, INDIA.

CORRESPONDENCE

Kiruthika Santhinathan

Dr. Gayathri KumararajaAssociate professor, Department of Pharmaceutics, Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore-641021, Tamil Nadu, INDIA.

gayubpharm@gmail.com

Received: 08-07-2024; Revised: 09-09-2024; Accepted: 09-01-2025.

Volume 59, Issue 2S · pp. s436–s442 · PUBLISHED Apr-Jun 2025 · DOI: 10.5530/ijper.20250292

View on IJPER original site ↗

ABSTRACT

Background: Cardiovascular Diseases (CVDs) are the main causes of death in both industrialized and developing nations, which are mostly brought on by poor lifestyles and insufficient physical activity. Recent years many novel approaches have been developed for effective drug delivery of cardiovascular drugs. Milrinone [MRN] is a cardiovascular medication that is mainly used in the intensive care unit and cardiac unit to provide cardiac support to patients suffering from acute heart failure. It is also used to wear patients who have pre-existing left ventricular dysfunction from cardiopulmonary bypass, or it can be used as a temporising agent for patients awaiting heart surgery or transplantation. Milrinone is poorly water soluble and milrinone salt was used in the market. Aims: This work aimed to develop; a bilosome carrier was used to enhance the bioavailability of MRN. Materials and Methods By using thin film hydration method the MRN Bilosomes were prepared. Results: The formulation shows spherical morphology by SEM image and particle size were found to be 120 nm±6.8. The formulation was stable which shows -37.2±2.3 mV of zeta potential. The drug release was 88±1.3% with the Entrapment efficiency of 81±1.7% w/w. Cellular uptake and cell viability studies were carried using H9c2 cells. Flowcytometry technique was used for cellular uptake study. The results indicate the fluorescence seen for the uptake of MRN-bilosomes by the cells. The MTT assay indicates there was 2-fold increases in cell viability of MRN-bilosomes when compared to milrinone lactate. Conclusion: These findings suggest that MRN bilosomes were effective against cardiovascular disease with increased bioavailability.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Santhinathan, K., Durai, S., Sirajudeen, R., Govindhraji, G., Gopal, S., & Kumararaja, G. (2025). Bilosome Nanocarriers for Enhanced Oral Bioavailability and Cardiovascular Activity of Milrinone. Indian Journal of Pharmaceutical Education and Research, 59(2S), s436–s442. https://doi.org/10.5530/ijper.20250292